MyMD Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 4/6
MyMD Pharmaceuticals has a total shareholder equity of $12.8M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $17.9M and $5.1M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$4.92m |
| Equity | US$12.77m |
| Total liabilities | US$5.09m |
| Total assets | US$17.86m |
Recent financial health updates
We Think MyMD Pharmaceuticals (NASDAQ:MYMD) Needs To Drive Business Growth Carefully
Sep 01
We're Keeping An Eye On MyMD Pharmaceuticals' (NASDAQ:MYMD) Cash Burn Rate
May 19Recent updates
We Think MyMD Pharmaceuticals (NASDAQ:MYMD) Needs To Drive Business Growth Carefully
Sep 01We're Keeping An Eye On MyMD Pharmaceuticals' (NASDAQ:MYMD) Cash Burn Rate
May 19MyMD Pharma receives grant from European patent office for Supera-CBD compound
Aug 30Oramed, MyMD surge on plans for early-stage oral COVID vaccine data release in Q3
Jul 08Companies Like MyMD Pharmaceuticals (NASDAQ:MYMD) Could Be Quite Risky
Apr 12MyMD Pharmaceuticals (NASDAQ:MYMD) Is In A Good Position To Deliver On Growth Plans
Aug 29Financial Position Analysis
Short Term Liabilities: MYMD's short term assets ($5.8M) exceed its short term liabilities ($5.0M).
Long Term Liabilities: MYMD's short term assets ($5.8M) exceed its long term liabilities ($100.5K).
Debt to Equity History and Analysis
Debt Level: MYMD is debt free.
Reducing Debt: MYMD has no debt compared to 5 years ago when its debt to equity ratio was 1.3%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: MYMD has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: MYMD has less than a year of cash runway if free cash flow continues to reduce at historical rates of 15.9% each year